| http://www.w3.org/ns/prov#value | - Such risks and uncertainties include, among others, the uncertainties inherent in the outcome of clinical trials, the timing of the availability of data from ongoing clinical trials, expectations for the timing of regulatory submissions and regulatory approvals, and other matters that could affect the availability or commercial potential of rolapitant, such as the availability of an intravenous fo
|
